Sandostatin(Octreotide Acetate Injection) Instructions:Uses,Dosage, Side Effects

1 / 1

Sandostatin(Octreotide Acetate Injection)

Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection

Reference price:

Manufacturer:

Novartis

Formulation:

INJECTION

Validity period:

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

BYNFEZIA PEN (octreotide acetate) is a somatostatin analogue used primarily for the treatment of hormone-related conditions, including acromegaly and certain types of tumors such as metastatic carcinoid and VIPomas. It works by inhibiting excessive secretion of growth hormone and other hormones, alleviating symptoms like flushing and diarrhea. The drug is administered via subcutaneous injection, which for patient self-administration.

BYNFEZIA PEN provides a critical management option for patients who have not responded well to surgery, irradiation, or other pharmacological treatments. It is a versatile and effective therapeutic tool in the management of these complex endocrine and gastrointestinal disorders.

Generic name

Sandostatin(Octreotide Acetate Injection)

English name

Octreotide Acetate Injection

Alternative Names

Sandostatin

Drug prices

Indications

1. Acromegaly: To reduce elevated levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in patients who are unresponsive to or ineligible for surgical resection, pituitary irradiation, or bromocriptine mesylate.

2. Metastatic Carcinoid Tumors: For symptomatic treatment of severe diarrhea and flushing episodes.

3. Vasoactive Intestinal Peptide Tumors (VIPomas): For the management of profuse watery diarrhea associated with VIP-secreting tumors.

Therapeutic Target

Somatostatin receptors in the endocrine and neuroendocrine systems, particularly in pituitary and gastrointestinal tract cells secreting GH, VIP, and other peptides.

Active Ingredients

Octreotide acetate (synthetic somatostatin analog)

Dosage form

INJECTION

specifications

30mg*1vial/box

Description

Octreotide is a synthetic long-acting cyclic octapeptide analog of the naturally occurring hormone somatostatin. It mimics the pharmacologic effects of somatostatin by inhibiting the secretion of several hormones including GH, insulin, glucagon, and various gastrointestinal peptides.

Dosage and Administration

Route: Subcutaneous injection into the abdomen, upper outer arm, or front of thighs; rotate injection sites.Administer at room temperature. Visually inspect for clarity and absence of particles.

1. Acromegaly: Initial dose: 50 mcg three times daily for 2 weeks; maintenance: 100–500 mcg three times daily.

2. Carcinoid Tumors: 100–600 mcg daily in 2–4 divided doses.

3. VIPomas: 200–300 mcg daily in 2–4 divided doses.

CATEGORY NAVIGATION